Literature DB >> 18850758

Loss aversion and cost effectiveness of healthcare programmes.

Afschin Gandjour1.   

Abstract

Mesh：

Year:  2008        PMID： 18850758     DOI： 10.2165/00019053-200826110-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  10 in total

1.  Is there a kink in consumers' threshold value for cost-effectiveness in health care?

Authors:  Bernie J O'Brien; Kirsten Gertsen; Andrew R Willan; Lisa A Faulkner
Journal:  Health Econ       Date:  2002-03       Impact factor: 3.046

2.  The other right-to-life debate: when does Fourteenth Amendment "life" end?

Authors:  Douglas O Linder
Journal:  Ariz Law Rev       Date:  1995

3.  Why cost-effectiveness should trump (clinical) effectiveness: the ethical economics of the South West quadrant.

Authors:  Jack Dowie
Journal:  Health Econ       Date:  2004-05       Impact factor: 3.046

4.  No room for kinkiness in a public healthcare system.

Authors:  Jack Dowie
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.

Authors:  Wilbert B van den Hout; Gijsbert W P M Kramer; Ed M Noordijk; Jan-Willem H Leer
Journal:  J Natl Cancer Inst       Date:  2006-12-20       Impact factor: 13.506

6.  The neural basis of loss aversion in decision-making under risk.

Authors:  Sabrina M Tom; Craig R Fox; Christopher Trepel; Russell A Poldrack
Journal:  Science       Date:  2007-01-26       Impact factor: 47.728

7.  Ethical economics and cost-effectiveness analysis: is it ethical to ignore opportunity costs?

Authors:  Pedram Sendi; Amiram Gafni; Stephen Birch
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2005-12       Impact factor: 2.217

Review 8.  Moral heuristics.

Authors:  Cass R Sunstein
Journal:  Behav Brain Sci       Date:  2005-08       Impact factor: 12.579

9.  Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem.

Authors:  A Gafni; S Birch
Journal:  CMAJ       Date:  1993-03-15       Impact factor: 8.262

Review 10.  Cost-effectiveness acceptability curves and a reluctance to lose.

Authors:  Johan L Severens; Daniëlle E M Brunenberg; Elisabeth A L Fenwick; Bernie O'Brien; Manuela A Joore
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981
  10 in total
  4 in total

1.  Loss aversion and cost effectiveness of healthcare programmes: whose aversion counts anyway?

Authors:  Johan L Severens; J L Hans Severens
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

2.  "Gaining or losing": The importance of the perspective in primary care health services valuation.

Authors:  Jesús Martín-Fernández; Gloria Ariza-Cardiel; Luz Mª Peña-Longobardo; Elena Polentinos-Castro; Juan Oliva-Moreno; Ana Isabel Gil-Lacruz; Héctor Medina-Palomino; Isabel Del Cura-González
Journal:  PLoS One       Date:  2017-12-05       Impact factor: 3.240

3.  Caveat emptor NICE: biased use of cost-effectiveness is inefficient and inequitable.

Authors:  Jack Dowie; Mette Kjer Kaltoft; Jesper Bo Nielsen; Glenn Salkeld
Journal:  F1000Res       Date:  2015-10-16

4.  Risk aversion, trust in institutions and contingent valuation of healthcare services: trying to explain the WTA-WTP gap in the Dutch population.

Authors:  Jesús Martín-Fernández; Ángel López-Nicolás; Juan Oliva-Moreno; Héctor Medina-Palomino; Elena Polentinos-Castro; Gloria Ariza-Cardiel
Journal:  Cost Eff Resour Alloc       Date:  2021-05-05
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.